GILD
GILEAD SCIENCES, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$150.11
−0.52%Forward multiples
Based on analyst estimates
- P/E forward
- 16.58x
- P/E 2026E
- —
- P/E 2027E
- 15.13x
- P/E 2028E
- 14.08x
- P/S forward
- 5.94x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 15.74x
- Price / sales
- 6.11x
- Price / cash flow
- 13.74x
Enterprise value
- Enterprise value
- $209.1B
- EV / sales
- 6.87x
- EV / EBITDA
- 328.79x
- EV / EBIT
- -140.06x
- Market cap
- $186.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026